2. PROTAC Protein Tyrosine Kinase/RTK Cell Cycle/DNA Damage
  3. Ligands for Target Protein for PROTAC FLT3 CDK
  4. 1572045-62-5

1572045-62-5

Rezvilutamide Chemical Structure

1572045-62-5

Chemical Structure

  • Rezvilutamide
  • Synonym(s): SHR3680
  • CAS No: 1572045-62-5
    Formula: C22H20F3N3O4S
    Molecular Weight: 479.47
  • IUPAC Name: (S)-4-(3-(4-(2,3-dihydroxypropoxy)phenyl)-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile
  • InChIKey: KRBMOYIWQCZVHA-INIZCTEOSA-N
  • SMILES: S=C(N(C(C=C1)=CC=C1OC[C@@H](O)CO)C(C)2C)N(C(C=C3)=CC(C(F)(F)F)=C3C#N)C2=O

Biological Activity: Rezvilutamide (SHR3680) is an orally active androgen receptor antagonist. Rezvilutamide (SHR3680) is used for the study of prostate cancer[1][2].

Cat. No. Product Name Purity Description
HY-137448 Rezvilutamide 99.76% Rezvilutamide (SHR3680) is an orally active androgen receptor antagonist. Rezvilutamide (SHR3680) is used for the study of prostate cancer.

References

[1]. SangjunYoo, et al. New drugs in prostate cancer. Prostate International Volume 4, Issue 2, June 2016, Pages 37-42.
[2]. Veronica Mollica, et al. Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer. Cells. 2019 Jan 11;8(1):43. [Content Brief]

Keywords:

Rezvilutamide